NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Jun 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 6h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ZELAPAR is an orally disintegrating tablet formulation of selegiline hydrochloride, a monoamine oxidase inhibitor (MAOI) used in the treatment of Parkinson's disease. The drug works by inhibiting the breakdown of dopamine in the brain, thereby prolonging its effects and reducing motor symptoms. It is typically used as an adjunctive therapy to levodopa in patients experiencing motor fluctuations.
$0.626MPart D
LOE ApproachingDeclining
With lifecycle status approaching LOE, the brand team is likely in maintenance mode with smaller commercial operations and reduced headcount investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ZELAPAR offers limited career growth opportunities given its LOE-approaching lifecycle and minimal linked job openings. Career moves on this product are best suited for professionals focused on defensive commercial strategy, narrow specialist populations, or transition roles managing end-of-life product transitions.
Brand ManagerField Sales Representative
Worked on ZELAPAR at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.